Immunology
336 FDA-approved drugs
Recent Approvals
EXDENSUR
DEPEMOKIMAB-ULAA
the add‑on maintenance treatment of severe asthma characterized by an eosinophilic phenotype in adul...
2025-12-16
GSK
LOTEPREDNOL ETABONATE AND TOBRAMYCIN
LOTEPREDNOL ETABONATE
ster...
2025-12-10
ALEMBIC
WAYRILZ
RILZABRUTINIB
adult patients with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient...
2025-08-29
Sanofi
BTK
OTEZLA XR
APREMILAST
adult patients and pediatric patients 6 years of age and older and weighing at least 20 kg with acti...
2025-08-29
Amgen
VYSCOXA
CELECOXIB
the management of acute pain or treatment of primary dysmenorrhea...
2025-07-29
CARWIN PHARM ASSOC
DOPTELET SPRINKLE
AVATROMBOPAG MALEATE
thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedu...
2025-07-24
AKARX INC
ANZUPGO
DELGOCITINIB
the topical treatment of moderate to severe chronic hand eczema (CHE) in adults who have had an inad...
2025-07-23
LEO PHARMA AS
JAK1JAK2JAK3
XIFYRM
MELOXICAM
use in adults for the management of moderate-to-severe pain, alone or in combination with non-NSAID ...
2025-06-05
AZURITY
STARJEMZA
ustekinumab-hmny
adults and pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who ...
2025-05-22
BIO-THERA SOLUTIONS LTD
IL-12IL-23
HALOBETASOL PROPIONATE AND TAZAROTENE
HALOBETASOL PROPIONATE
the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses...
2025-05-02
SUN PHARMA CANADA
QAMZOVA
MELOXICAM
use in adults for the management of moderate-to-severe pain, alone or in combination with non-NSAID ...
2025-04-22
NANJING DELOVA
SYMBRAVO
MELOXICAM
cluster headache...
2025-01-30
AXSOME
AVTOZMA
TOCILIZUMAB-ANOH
adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate re...
2025-01-24
CELLTRION INC
IL-6
YESINTEK
USTEKINUMAB-KFCE
adults and pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who ...
2024-11-29
BIOCON BIOLOGICS INC
IL-12IL-23
EMROSI
MINOCYCLINE HYDROCHLORIDE
EMROSI is indicated to treat inflammatory lesions (papules and pustules) of rosacea in adults...
2024-11-01
JOURNEY
IMULDOSA
USTEKINUMAB-SRLF
adults and pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who ...
2024-10-10
ACCORD BIOPHARMA INC.
IL-12IL-23
OTULFI
USTEKINUMAB-AAUZ
adults and pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who ...
2024-09-27
Fresenius Kabi
IL-12IL-23
EBGLYSS
LEBRIKIZUMAB-LBKZ
adults and pediatric patients 12 years of age and older who weigh at least 40 kg with moderate-to-se...
2024-09-13
Eli Lilly
IL-13IL-4R
NEMLUVIO
NEMOLIZUMAB-ILTO
adults with prurigo nodularis...
2024-08-12
GALDERMA LABS LP
LEQSELVI
DEURUXOLITINIB PHOSPHATE
adult patients with severe alopecia areata...
2024-07-25
Sun Pharma
JAK1JAK2JAK3
Showing 20 of 336 drugs
Top Companies
Drug Classes
Nonsteroidal Anti-inflammatory Drug 34
Corticosteroid 27
Calcineurin Inhibitor Immunosuppressant 12
Tumor Necrosis Factor Blocker 12
Retinoid 10
Aminosalicylate 7
Interleukin-12 Antagonist 6
Janus Kinase Inhibitor 5
Interleukin-6 Receptor Antagonist 5
Phosphodiesterase 4 Inhibitor 4
Quick Stats
- Total Drugs
- 336
- Companies
- 151
- Drug Classes
- 53
- Latest Approval
- 2025-12-16